Clinical trial

Nanotechnology for Detection of Multiple Sclerosis Compared to Autoimmune and Neurological Diseases by Exhaled Samples

NCT01465087

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-12-01

PhaseNA

Study timeline

Study start (unknown)2011-12-01Date precision: month

Registry last updated2016-06-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

NA-NOSE artificial olfactory systemOTHER

Sponsors & collaborators

Carmel Medical Centerlead sponsor

Technion, Israel Institute of Technologycollaborator

Mapped research locations

HaifaIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01465087 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.